Front cover image for Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality

Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality

"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."--Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union."--Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.; "Regulating Pharmaceuticals in Europe" is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors are: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors include: Julia Abelson, Christa Altenstetter, Vittorio Bertele', Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W.; Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, and Tom Walley
eBook, English, 2004
Open University Press, Maidenhead, 2004
1 online resource (xix, 368 pages) : illustrations.
9780335226559, 9780335214655, 9780335214662, 9781280947353, 9786610947355, 0335226558, 0335214657, 0335214665, 1280947357, 661094735X
191935038
Regulating pharmaceuticals in Europe : an overview / Elias Mossialos, Tom Walley and Monique Mrazek
The politics of pharmaceuticals in the European Union / Govin Permanand and Christa Altenstetter
The European Community dimension : coordinating divergence / Leigh Hancher
The role of the EMEA in regulating pharmaceutical products / Silvio Garattini and VIttorio Bertele'
Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector / Panos Kanavos [and others]
Regulating pharmaceutical prices in the European Union / Monique Mrazek and Elias Mossialos
Reimbursement of pharmaceuticals in the European Union / Alistair McGuire, Michael Drummond and Frans Rutten
Good prescribing practice / Steve Chapman, Pierre Durieux and Tom Walley
Patients and their medicines / Colin Bradley, Ebba Holme Hansen and Sjoerd Kooiker
Financial incentives and prescribing / Tom Walley and Elais Mossialos
Regulating pharmaceutical distribution and retail pharmacy in Europe / David Taylor, Monique Mrazek and Elias Mossialos
Hospital pharmacies / Steve Hudson
Influencing demand for drugs through cost sharing / Sarah Thomson and Elias Mossialos
The off-patent pharmaceutical market / Christine M. Bond [and others]
The implications of pharmacogenetics and pharmacogenomics for drug development and health care / Munir Pirmohamed and Graham Lewis
Should we pay for lifestyle drugs? / Tom Walley
Alternative medicines in Europe / Edzard Ernst and Anna Dixon
The pharmaceutical sector and regulation in the countries of Central and Eastern Europe / Monique Mrazek [and others]
Access to pharmaceuticals and regulation in the Commonwealth of Independent States / Moninque Mrazek and Armin Fidler
A framework for containing costs fairly / Donald W. Light and Tom Walley
English